Breaking through convention to simplicity in type 2 diabetes care – Case study 2

shutterstock_1891498816 - image for home page

This expert-led case study uses fixed-dose combination insulin/GLP-1 agonist therapy to reduce complications of type 2 diabetes mellitus

Learning objectives

You will learn:

  • The benefits of using fixed-dose combination insulin/GLP-1 agonist therapy to reduce complications of type 2 diabetes mellitus (T2DM)
  • An understanding of the mechanism of action of GLP-1 agonists and how to use these agents safely and effectively
  • An understanding of the criteria that determine individualised HbA1c targets
  • An approach to the management of comorbid dyslipidaemia and hypertension.

To access this module, please register or login: